Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hanmi Semiconductor (042700) – Provisional Operating Results (Consolidated) / 2025-10-31 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | ADR Listing · Valuation Gap · Re-rating / 2026-03-25 RESEARCH
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Sales and Supply Contract / 2026-06-30 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Decision on Share Repurchase / 2026-03-04 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-08-20 Semiconductors
  • [Disclosure] Samsung Electro-Mechanics (009150) – Decision to Call Annual General Meeting of Shareholders / 2026-02-12 Semiconductors
  • [Disclosure] SK Square (402340) – Correction of Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-03-03 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Production Halt / 2025-10-17 Disclosures

Category: Disclosures

[Disclosure] ALTEOGEN (196170) – EYZANFY (ALT-L9, Eylea Biosimilar) Approved for Product License by MFDS / 2026-05-15

Posted on May 15, 2026August 5, 2026 By K-STOCK Editor
[Disclosure] ALTEOGEN (196170) – EYZANFY (ALT-L9, Eylea Biosimilar) Approved for Product License by MFDS / 2026-05-15

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ALTEOGEN received official product license approval from the Ministry of Food and Drug Safety (MFDS) for EYZANFY (ALT-L9), an Eylea biosimilar, covering all indications approved for the original drug. 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of…

Read More “[Disclosure] ALTEOGEN (196170) – EYZANFY (ALT-L9, Eylea Biosimilar) Approved for Product License by MFDS / 2026-05-15” »

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Additional Listing (Exercise of Stock Options) / 2026-05-15

Posted on May 15, 2026August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Additional Listing (Exercise of Stock Options) / 2026-05-15

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Following the exercise of stock options by Celltrion officers and employees, a total of 184,080 new common shares will be issued and additionally listed on May 20, 2026. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Total Issued…

Read More “[Disclosure] Celltrion (068270) – Additional Listing (Exercise of Stock Options) / 2026-05-15” »

Disclosures, Bio & Healthcare

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-05-15

Posted on May 15, 2026July 31, 2026 By K-STOCK Editor
[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-05-15

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanmi Semiconductor will participate in a conference sponsored by Macquarie Securities in Hong Kong to present key business updates to major overseas institutional investors, including new equipment launches for AI system semiconductors and participation in a U.S.-led AI alliance. 📊 [Key Disclosure Contents & Summary of…

Read More “[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-05-15” »

Semiconductors, Disclosures

[Disclosure] Hanmi Semiconductor (042700) – Provisional Financial Results (Consolidated) / 2026-05-15

Posted on May 15, 2026July 31, 2026 By K-STOCK Editor
[Disclosure] Hanmi Semiconductor (042700) – Provisional Financial Results (Consolidated) / 2026-05-15

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanmi Semiconductor reported Q1 2026 provisional consolidated financial results with revenue of KRW 50.9B and operating profit of KRW 8.5B. 📊 [Key Disclosure Contents & Summary of Major Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Finalized Financial Results and Detailed Statements in Quarterly…

Read More “[Disclosure] Hanmi Semiconductor (042700) – Provisional Financial Results (Consolidated) / 2026-05-15” »

Semiconductors, Disclosures

[Disclosure] Hana Micron (067310) – Corporate Value-up Plan (Voluntary Disclosure) (2025 Implementation Status) / 2026-05-14

Posted on May 14, 2026August 2, 2026 By K-STOCK Editor
[Disclosure] Hana Micron (067310) – Corporate Value-up Plan (Voluntary Disclosure) (2025 Implementation Status) / 2026-05-14

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hana Micron voluntarily disclosed the “2025 Corporate Value-up Plan Implementation Status,” reporting FY2025 consolidated revenue of KRW 1.5344 trillion, ROIC of 6.3%, and a dividend of KRW 70 per share toward achieving its value-up targets. 📊 [Key Disclosure Contents & Summary Metrics] 1. Plan Title &…

Read More “[Disclosure] Hana Micron (067310) – Corporate Value-up Plan (Voluntary Disclosure) (2025 Implementation Status) / 2026-05-14” »

Semiconductors, Disclosures

[Disclosure] HPSP (403870) – Resolution on Calling of General Meeting of Shareholders / 2026-05-13

Posted on May 13, 2026August 1, 2026 By K-STOCK Editor
[Disclosure] HPSP (403870) – Resolution on Calling of General Meeting of Shareholders / 2026-05-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary HPSP decided to hold an extraordinary general meeting of shareholders on June 25, 2026, to vote on the appointment of Kevin Gidoo Lee as a new executive director. 📊 Key Disclosure Contents & Summary Metrics 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Confirmation of Venue Details…

Read More “[Disclosure] HPSP (403870) – Resolution on Calling of General Meeting of Shareholders / 2026-05-13” »

Disclosures, Semiconductors

[Disclosure] HPSP (403870) – Record Date or Book Closing / 2026-05-13

Posted on May 13, 2026August 1, 2026 By K-STOCK Editor
[Disclosure] HPSP (403870) – Record Date or Book Closing / 2026-05-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary HPSP established May 28, 2026, as the record date to determine eligible voting shareholders for an upcoming extraordinary general meeting of shareholders. 📊 Key Disclosure Contents & Summary Metrics 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Identification of Voting Shareholders and General Meeting Agendas This disclosure…

Read More “[Disclosure] HPSP (403870) – Record Date or Book Closing / 2026-05-13” »

Disclosures, Semiconductors

[Disclosure] KEPCO (015760 / KEP) – Provisional Consolidated Financial Results (Fair Disclosure) / 2026-05-13

Posted on May 13, 2026August 12, 2026 By K-STOCK Editor
[Disclosure] KEPCO (015760 / KEP) – Provisional Consolidated Financial Results (Fair Disclosure) / 2026-05-13

Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO reported consolidated provisional operating profit of approximately KRW 3.78 trillion for Q1 2026, representing a 0.8% increase year-on-year. 📊 Key Disclosure Content & Financial Highlights • Disclosure Title: Provisional Consolidated Financial Results (Fair Disclosure) • Reporting Period: January 01, 2026 – March…

Read More “[Disclosure] KEPCO (015760 / KEP) – Provisional Consolidated Financial Results (Fair Disclosure) / 2026-05-13” »

Disclosures, Energy

[Disclosure] ALTEOGEN (196170) – Additional Listing (Exercise of Stock Options) / 2026-05-13

Posted on May 13, 2026August 5, 2026 By K-STOCK Editor
[Disclosure] ALTEOGEN (196170) – Additional Listing (Exercise of Stock Options) / 2026-05-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ALTEOGEN will issue and list 52,500 additional common shares on May 18, 2026, following the exercise of stock options. 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Additional Listing Schedule Execution and Share Count Update This disclosure…

Read More “[Disclosure] ALTEOGEN (196170) – Additional Listing (Exercise of Stock Options) / 2026-05-13” »

Disclosures, Bio & Healthcare

[Disclosure] SK Square (402340) – Decision on Disposal of Treasury Stocks / 2026-05-13

Posted on May 13, 2026July 31, 2026 By K-STOCK Editor
[Disclosure] SK Square (402340) – Decision on Disposal of Treasury Stocks  / 2026-05-13

Fact Source: Financial Supervisory Service DART 💡 Summary SK Square’s subsidiary, SK Hynix, is disposing of 191 treasury shares to settle a retired executive’s stock option exercise, while reporting the entire remaining pool of 114,209 shares granted at the same general meeting pursuant to disclosure regulations. 📊 Key Disclosure Contents & Financial Highlights 📝 Editor’s…

Read More “[Disclosure] SK Square (402340) – Decision on Disposal of Treasury Stocks / 2026-05-13” »

Semiconductors, Disclosures

Posts pagination

Previous 1 … 21 22 23 … 252 Next
  • [Disclosure] Celltrion (068270) – Execution of License-in Agreement for Novel Drug Candidates for Rare Autoimmune Diseases / 2025-11-04 Disclosures
  • [Disclosure] SK Square(402340) – Decision on Disposal of Treasury Shares / 2024-04-24 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-08-20 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – (Correction) Future Business and Management Plans (Fair Disclosure) / 2026-01-29 Disclosures
  • [Disclosure] Celltrion (068270) – Submission of Application for Phase 3 Clinical Trial Plan for CT-P44 (Darzalex Biosimilar) in the US / 2024-12-02 Disclosures
  • [Disclosure] HPSP (403870) – Decision on Cash and In-Kind Dividend / 2025-02-13 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Paid-in Capital Increase Decision / 2025-12-22 Disclosures
  • [Disclosure] Celltrion (068270) – Decision on Acquisition of Treasury Shares / 2025-09-17 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme